iA Global Asset Management’s Edwards Lifesciences EW Stock Holding History

iA Global Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,174	Closed	-$574K	–	486
2026 Q1	$574K	Buy	+7,174	New	+$591K	0.01%	329
2024 Q3	–	Sell	-1,310	Closed	-$121K	–	494
2024 Q2	$121K	Sell	1,310 -35,670	-96%	-$3.16M	﹤0.01%	457
2024 Q1	$3.53M	Sell	36,980 -16,669	-31%	-$1.4M	0.07%	187
2023 Q4	$4.09M	Buy	53,649 +3,974	+8%	+$277K	0.09%	169
2023 Q3	$3.44M	Buy	49,675 +2,850	+6%	+$229K	0.09%	170
2023 Q2	$4.42M	Buy	+46,825	New	+$4.07M	0.12%	144

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

iA Global Asset Management's EW Position: Q2 2026 in Review

iA Global Asset Management sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 7,174 shares — an estimated $574K sold.

iA Global Asset Management first reported a position in EW in Q2 2023 and held it in 6 quarters. The position peaked at $4.42M in Q2 2023. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

iA Global Asset Management reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
iA Global Asset Management sold 7,174 Edwards Lifesciences shares in Q2 2026, an estimated $574K.
iA Global Asset Management first reported a position in Edwards Lifesciences in Q2 2023 and held it in 6 quarters.
iA Global Asset Management's Edwards Lifesciences position peaked at $4.42M in Q2 2023.
1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.